Where does Robert DeBenedetto work?

Robert DeBenedetto is Managing Director, CCD at Abingworth.

What does Robert DeBenedetto invest in?

Robert DeBenedetto invests in Biotech.

What boards does Robert DeBenedetto sit on?

Robert DeBenedetto holds tracked board seats at SFJ Pharmaceuticals, Inc..

Where did Robert DeBenedetto go to school?

Robert DeBenedetto studied at Bentley University - McCallum Graduate School of Business (Masters); Northeastern University (Bachelors, Accounting & Finance).

Robert DeBenedetto

Investor

Managing Director, CCD at Abingworth

Pleasanton, California, United States

Find your path to Robert

138 people in our graph share verified history with Robert — schools, employers, funds. One of them is your warm intro.

Jim BreyerunlockedRobert: together at Blackstone Life Sciences (2018–2023)

Robert: together at Blackstone Life Sciences

×8Robert: together at Bentley University - McCallum Graduate School of Business

×2Robert: together at Abingworth

About

Robert DeBenedetto joined Abingworth in August 2024 with over 30 years of experience in the life science industry. He previously founded and led SFJ Pharmaceuticals as President and CEO, worked as a Senior Advisor to Blackstone Life Sciences, and held earlier roles at Quintiles (now IQVIA), Boston Scientific, and EY. He holds a Master's degree from Bentley University.

Invests in

Biotech

Experience

Abingworth (a Carlyle company)Managing Directorcurrent2024 — presentSan Francisco, California, United States
SFJ Pharmaceuticals, Inc.Executive Chair of the Board of Directorscurrent2008 — presentPleasanton, California, United States
SFJ Pharmaceuticals, Inc.President & CEO2008 — 2023
Blackstone Life SciencesSenior Adviser, Blackstone Life Sciences2018 — 2023
NovaQuestV.P. Global Business Development2004 — 2008
Boston Scienitific CorporationCFO, Executive Board Member, Boston Scientifc Japan1995 — 2003
Ernst & YoungSenior Manager1990 — 1995

Skills & more

Strategy17Strategic Planning4Sales Management4Program Management7Business Development6Commercialization11Mergers & Acquisitions11Regulatory Affairs5Lifesciences3Investments4Strategic Alliances7Corporate Development4

+11 more

MarketingPharmaceutical IndustryClinical TrialsGlobal Business DevelopmentMedical DevicesClinical DevelopmentMergersBiotechnologyTechnology TransferPharmaceuticsLicensing

From Robert's professional profile.

Investments

Board seats

SFJ Pharmaceuticals, Inc.

Per the firm's website.

Colleagues at Abingworth

Alex Asquith

Counsel at Abingworth

Amit Khasgiwala

Investment Professional at Innovatus Capital Partners

Andrew Sinclair

Managing Director, Head of Publics & Late Stage at Abingworth

Ankur Shah

Vice President, CCD at Abingworth

Anna Slezak

Senior Associate at Abingworth

Bali Muralidhar

Global Head of Life Sciences & CIO at Abingworth

Carlos Paya

Venture Partner at Ysios Capital

David Leathers

General Partner at Abingworth

Frequently asked questions

Who is Robert DeBenedetto?: Robert DeBenedetto joined Abingworth in August 2024 with over 30 years of experience in the life science industry. He previously founded and led SFJ Pharmaceuticals as President and CEO, worked as a Senior Advisor to Blackstone Life Sciences, and held earlier roles at Quintiles (now IQVIA), Boston Scientific, and EY. He holds a Master's degree from Bentley University.
Where does Robert DeBenedetto work?: Robert DeBenedetto is Managing Director, CCD at Abingworth.
What does Robert DeBenedetto invest in?: Robert DeBenedetto invests in Biotech.
What boards does Robert DeBenedetto sit on?: Robert DeBenedetto holds tracked board seats at SFJ Pharmaceuticals, Inc..
Where did Robert DeBenedetto go to school?: Robert DeBenedetto studied at Bentley University - McCallum Graduate School of Business (Masters); Northeastern University (Bachelors, Accounting & Finance).

Same school

Also attended Bentley University - McCallum Graduate School of Business33

Ava BrunelleInvestor at Third Rock Ventures Gabriella WilliamsInvestor at Third Rock Ventures Kevin GillisPartner and Chief Operating Officer at Third Rock Ventures Jessica WongController at Illumina Ventures Ullas NaikFounder and General Partner at Streamlined Ventures Chris MooreChief Financial Officer at K5 Global

+ 27 more

Also attended Northeastern University477

Matt GuineyChief Financial Officer at Flybridge Capital Partners Allison KuziwGlobal Human Resources Executive at Marlin Equity Partners Saunaz MoradiPartner, Communications at Lux Capital Brian DixonManaging Partner at Kapor Capital Murat BicerGeneral Partner at CRV (Charles River Ventures)Christopher WolfChief Financial Officer at MPM BioImpact

+ 471 more

Shared employers

Also worked at SFJ Pharmaceuticals, Inc.4

Kurt von EmsterManaging Partner at Abingworth Emmett CunninghamExecutive Officer, Director at Eyconis Svai SanfordExecutive Officer at Rani Therapeutics Holdings Barbara WhiteGeneral Partner at Banyan BioInnovations Capital

Also worked at Ernst & Young2,000

Tyler WilsonSenior Accountant at Felicis Ventures Sandra SchwarzerInvestor at Index Ventures TorjusInvestor at Investinor Angela ToyPartner & COO at Golden Gate Ventures Kirsten MelloPartner + Chief Financial Officer at Menlo Ventures Hark AhluwaliaAssociate at Revolution

+ 1,994 more